Lazard Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866K | Sell |
|
|||||
|
2025
Q1 | $768K | Sell |
|
|||||
|
2024
Q4 | $1.28M | Buy |
|
|||||
|
2024
Q3 | $2.1M | Sell |
|
|||||
|
2024
Q2 | $2.6M | Buy |
|
|||||
|
2024
Q1 | $2.48M | Sell |
|
|||||
|
2023
Q4 | $3.12M | Sell |
|
|||||
|
2023
Q3 | $3.35M | Sell |
|
|||||
|
2023
Q2 | $4.38M | Buy |
|
|||||
|
2023
Q1 | $3.97M | Buy |
|
|||||
|
2022
Q4 | $1.66M | Sell |
|
|||||
|
2022
Q3 | $4.89M | Buy |
|
|||||
|
2022
Q2 | $4.27M | Buy |
|
|||||
|
2022
Q1 | $39K | Buy |
|
|||||
|
2021
Q4 | $47K | Buy |
|
|||||
|
2021
Q3 | $1K | Buy |
|